PT3554474T - Composições de micafungina - Google Patents
Composições de micafunginaInfo
- Publication number
- PT3554474T PT3554474T PT178294120T PT17829412T PT3554474T PT 3554474 T PT3554474 T PT 3554474T PT 178294120 T PT178294120 T PT 178294120T PT 17829412 T PT17829412 T PT 17829412T PT 3554474 T PT3554474 T PT 3554474T
- Authority
- PT
- Portugal
- Prior art keywords
- micafungin
- compositions
- micafungin compositions
- Prior art date
Links
- 108010021062 Micafungin Proteins 0.000 title 1
- PIEUQSKUWLMALL-YABMTYFHSA-N micafungin Chemical compound C1=CC(OCCCCC)=CC=C1C1=CC(C=2C=CC(=CC=2)C(=O)N[C@@H]2C(N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)N3C[C@H](C)[C@H](O)[C@H]3C(=O)N[C@H](O)[C@H](O)C2)[C@H](O)CC(N)=O)[C@H](O)[C@@H](O)C=2C=C(OS(O)(=O)=O)C(O)=CC=2)[C@@H](C)O)=O)=NO1 PIEUQSKUWLMALL-YABMTYFHSA-N 0.000 title 1
- 229960002159 micafungin Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662435695P | 2016-12-16 | 2016-12-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT3554474T true PT3554474T (pt) | 2024-02-12 |
Family
ID=60972375
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT178294120T PT3554474T (pt) | 2016-12-16 | 2017-12-15 | Composições de micafungina |
Country Status (11)
Country | Link |
---|---|
US (1) | US20180169180A1 (pt) |
EP (1) | EP3554474B1 (pt) |
JP (2) | JP2020510619A (pt) |
AU (1) | AU2017376960B2 (pt) |
DK (1) | DK3554474T3 (pt) |
ES (1) | ES2972008T3 (pt) |
FI (1) | FI3554474T3 (pt) |
HU (1) | HUE066069T2 (pt) |
PL (1) | PL3554474T3 (pt) |
PT (1) | PT3554474T (pt) |
WO (1) | WO2018112330A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111044636A (zh) * | 2019-12-30 | 2020-04-21 | 卓和药业集团有限公司 | 米卡芬净含量的分析方法 |
US20220040092A1 (en) * | 2020-06-27 | 2022-02-10 | RK Pharma Solutions LLC | Ready to use injectable formulations of Micafungin Sodium |
CN112710753A (zh) * | 2020-12-18 | 2021-04-27 | 卓和药业集团有限公司 | 米卡芬净有关物质的分析方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5849843A (en) | 1993-11-16 | 1998-12-15 | Baxter International Inc. | Polymeric compositions for medical packaging and devices |
US5998019A (en) | 1993-11-16 | 1999-12-07 | Baxter International Inc. | Multi-layered polymer structure for medical products |
TWI233805B (en) | 1999-07-01 | 2005-06-11 | Fujisawa Pharmaceutical Co | Stabilized pharmaceutical composition in lyophilized form as antifungal agent |
US6991800B2 (en) * | 2002-06-13 | 2006-01-31 | Vicuron Pharmaceuticals Inc. | Antifungal parenteral products |
US20110071072A1 (en) * | 2009-08-28 | 2011-03-24 | Georgetown University, A Congressionally Chartered Institution Of Higher Education | Antifungal Bone Cements |
CN102614492B (zh) * | 2011-01-31 | 2013-12-11 | 上海天伟生物制药有限公司 | 一种含有棘白菌素类抗真菌剂米卡芬净的液体药用组合物 |
CN102775476B (zh) * | 2011-05-12 | 2015-01-07 | 上海天伟生物制药有限公司 | 一种米卡芬净钠盐的制备方法 |
CN102512379B (zh) * | 2011-12-16 | 2017-03-08 | 深圳市健元医药科技有限公司 | 一种新型棘白菌素类抗真菌药物组合物及其制备方法 |
WO2016107890A1 (en) * | 2014-12-31 | 2016-07-07 | Galenicum Health S.L. | Stable pharmaceutical compositions comprising micafungin |
AU2016334826B2 (en) * | 2015-10-07 | 2020-08-27 | Sumitomo Pharma Co., Ltd. | Pyrimidine compound |
WO2017060923A1 (en) * | 2015-10-10 | 2017-04-13 | Gufic Biosciences Limited | Freeze dried parenteral formulation of micafungin sodium and to process thereof |
-
2017
- 2017-12-15 FI FIEP17829412.0T patent/FI3554474T3/fi active
- 2017-12-15 US US15/843,634 patent/US20180169180A1/en active Pending
- 2017-12-15 PT PT178294120T patent/PT3554474T/pt unknown
- 2017-12-15 EP EP17829412.0A patent/EP3554474B1/en active Active
- 2017-12-15 AU AU2017376960A patent/AU2017376960B2/en active Active
- 2017-12-15 HU HUE17829412A patent/HUE066069T2/hu unknown
- 2017-12-15 ES ES17829412T patent/ES2972008T3/es active Active
- 2017-12-15 JP JP2019529625A patent/JP2020510619A/ja not_active Withdrawn
- 2017-12-15 PL PL17829412.0T patent/PL3554474T3/pl unknown
- 2017-12-15 WO PCT/US2017/066652 patent/WO2018112330A1/en unknown
- 2017-12-15 DK DK17829412.0T patent/DK3554474T3/da active
-
2023
- 2023-11-06 JP JP2023189549A patent/JP2024012211A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ES2972008T3 (es) | 2024-06-10 |
HUE066069T2 (hu) | 2024-07-28 |
JP2020510619A (ja) | 2020-04-09 |
AU2017376960B2 (en) | 2023-12-14 |
PL3554474T3 (pl) | 2024-04-15 |
JP2024012211A (ja) | 2024-01-25 |
EP3554474B1 (en) | 2023-12-06 |
DK3554474T3 (da) | 2024-02-19 |
AU2017376960A1 (en) | 2019-05-23 |
EP3554474A1 (en) | 2019-10-23 |
FI3554474T3 (fi) | 2024-02-21 |
WO2018112330A1 (en) | 2018-06-21 |
US20180169180A1 (en) | 2018-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20210342T8 (hr) | Pripravci glikopeptida | |
IL261792B (en) | Preparations | |
IL260933A (en) | Preparations containing tocorsol or its analogues | |
SG11201705415YA (en) | Multi-supplement compositions | |
IL257131A (en) | Preparations | |
GB201610156D0 (en) | Cliptac compositions | |
HK1251559A1 (zh) | 普那布林組合物 | |
GB201501598D0 (en) | Compositions | |
GB201515387D0 (en) | Compositions | |
GB201515391D0 (en) | Compositions | |
SI3349766T1 (sl) | Antihemoragični sestavki | |
GB201614799D0 (en) | Compositions | |
PL3058958T3 (pl) | Kompozycja anidulafunginy | |
PT3554474T (pt) | Composições de micafungina | |
GB201622161D0 (en) | Compositions | |
GB2538335B (en) | Compositions | |
PL3393503T3 (pl) | Kompozycje | |
GB201602658D0 (en) | Compositions | |
GB201614230D0 (en) | Compositions | |
GB201611960D0 (en) | Compositions | |
GB201611851D0 (en) | Compositions | |
GB201602656D0 (en) | Compositions | |
GB201522892D0 (en) | Compositions | |
GB201511469D0 (en) | Compositions | |
GB201507673D0 (en) | Compositions |